- About Lung Cancer
- Support & Resources
- Make a Difference
The ALERT (Access to Life Saving, Early Detection, Research and Treatment) Act, S. 717 deals with the entire continuum of cancer care. Prevention and early detection for those most at risk are emphasized through support for innovative initiatives and new technologies such as biomarkers and imaging. Cancer research will be strengthened through increased coordination among stakeholders on current and future projects. Increased enrollment in clinical research will be achieved by removing barriers to patients’ participating in clinical trials. The bill also includes measures to improve services for cancer survivors, reduce the duplication of services, and enhance continuity of care. Additionally the bill increases access to care for underserved populations and reduces the burden of disease and the cost of health care for the nation. The ALERT Act has been referred to the Senate Health Education Labor Pension (HELP) Committee.
To view a section by section summary of the legislation, click here.
March, 2010 [Washington, DC] -- LCA, an active member of the Lethal Cancers Coalition, continues its advocacy work with members of the US House of Representatives and staff on the development of the ALERT (Access to Life Saving, Early Detection, Research and Treatment) Act, first introduced by Senator Ted Kennedy in 2008. This effort is aimed at securing a specially targeted research program for those cancers, such as lung cancer, with 5-year survival rates of less than 50%.
Lung Cancer Alliance will continue to monitor and provide updates as this legislation moves forward.
June 8, 2009 [Washington, DC] -- The Kennedy-Hutchison cancer bill, entitled The 21st Century Cancer ALERT Act,, has been put on hold by the Senate leadership in deference to Senator Kennedy who is battling brain cancer. The House version of the bill is still being drafted. LCA has been working with the lethal cancer coalition and the staffs of the primary House sponsors to secure a special additional research program for those cancers, like lung cancer, with 5-year survival rates of less than 50%.
May 4, 2009 [Washington, DC] -- LCA Lead Voice for Lung Cancer Community in Advocating for Targeted Research Grant Funding for Eight Most Lethal Cancers in Senate ALERT Act, S. 717. Click here to read more.